Understanding the cancer risk in children with birth defects
Understanding the cancer risk in children with birth defects has been a challenge. Although scientific studies suggest that birth defects increase the risk of cancer,
Read More
Trading a spear for a trident is promising in the fight against leukemia
Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. While most children respond well to chemotherapy, some experience resistant or relapsed disease. Building on
Read More
From my perspective: Dr. Jeremy Schraw shares his experiences during postdoctoral training
From the Labs interviewed Dr. Jeremy Schraw to learn about his experiences during his postdoctoral training at Baylor College of Medicine and Texas Children’s Hospital.
Read More
Applying basic science helps predict poor treatment outcomes in ALL
The survival of patients with pediatric acute lymphoblastic leukemia (ALL) has significantly improved in the last several decades, but there is still a group of
Read More
Exploring the risk of ALL in children with Down syndrome
Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. Children with trisomy 21 (Down syndrome) are 10 to 20 times more likely to develop ALL
Read More